Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Enrolling by Invitation

Investigation of Lipedema, Lymphedema and Vascular Malformations by Multispectral Optoacoustic Tomography (MSOT)

NCT06399367

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +8 more
Locations: Universitätsmedizin Göttingen Göttingen, Lower Saxony, Germany

View Trial Details

Enrolling by Invitation

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

NCT05690191

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Second Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Enrolling by Invitation

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

NCT04491721

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, China

View Trial Details

Not Yet Recruiting

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

NCT07524530

Conditions: Core Binding Factor Alpha Subunits, Hematologic Diseases, Hematologic Neoplasms, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Not Yet Recruiting

Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT07572136

Conditions: Acute Lymphoblastic Leukemia, B-ALL, Hematologic Diseases, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Not Yet Recruiting

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

NCT06970496

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

Zhujiang Hospital of Southern Medical University Guangzhou, China

Jiangxi Cancer Hospital Nanchang, China

Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China

View Trial Details

Not Yet Recruiting

Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study

NCT07662928

Conditions: Adult Burkitt Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Not Yet Recruiting

Lazarus: IT Therapy for ICANS

NCT07763210

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Not Yet Recruiting

R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma

NCT07764601

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: The First People's Hospital of Changzhou Changzhou, Jiangsu, China

The First People's Hospital of Huai'an Huai'an, Jiangsu, China

The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

Wuxi People's Hospital Wuxi, Jiangsu, China

View Trial Details

Not Yet Recruiting

Evaluation of Iopofosine I 131 vs. R-CD in WM Patients

NCT07766421

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Not specified

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions